To escape immunosurveillance, cancer cells have developed mechanisms that mask their immunogenic features, such as expression of ligands for inhibitory receptors that directly inhibit T cell responses by engaging immune inhibitory receptors, such as PD-1 (ref. 1). This evidence concerns the gene PDCD1 and cancer.